KR

Krishnan Raghavendran

Active Director Director DIN 10876516
DIN 10876516 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishnan Raghavendran

Data last updated:

Krishnan Raghavendran is a Director at Parmm Foundation For Advancement Of Research In Biomedical Sciences (since 2024).

DIN 10876516
Primary Designation Director
First Appointment 18 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Dec 20242024Active

Directorship timeline

Open interactive timeline →
Parmm Foundation For Advancement Of Research In Biomedical Sciences
Premium access

Shareholding and investment profile for Krishnan Raghavendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishnan Raghavendran

Krishnan Raghavendran currently holds 1 directorship: Parmm Foundation For Advancement Of Research In Biomedical Sciences (Director, since 18 Dec 2024).

Krishnan Raghavendran was first appointed on 18 Dec 2024 as Director at Parmm Foundation For Advancement Of Research In Biomedical Sciences.

The current boards of Krishnan Raghavendran's companies include Ajai Kumar Malhotra (Parmm Foundation For Advancement Of Research In Biomedical Sciences), Misra Chandra Mahesh (Parmm Foundation For Advancement Of Research In Biomedical Sciences), Swati Singh (Parmm Foundation For Advancement Of Research In Biomedical Sciences).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available